New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles

References

• Sarkar S, Horn G, Moulton K. Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci. 2013;14(10):21087–21113.
   PubMed Web of Science ®Google Scholar
• Portenoy RK. Treatment of cancer pain. Lancet. 2011;377(9784):2236–2247.
   PubMed Web of Science ®Google Scholar
• Uyar M. Inceleme yazıları meme kanserlerinde agrı tedavısı. SSK Tepecık Hast Derg. 2002;12(1):1–12.
   Google Scholar
• Schneider G, Voltz R, Gaertner J. Cancer pain management and bone metastases: an update for the clinician. Breast Care (Basel). 2012;7(2):113–120.
   PubMed Web of Science ®Google Scholar
• Sultan A, McQuay HJ, Moore RA, et al. Single dose oral flurbiprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009;2009(3):1–39.
   Google Scholar
• Yin Y, Yi Y, Yu J, et al. Effects of flurbiprofen on serum level of interleukin-6, prostacyclin and corticosteroid A2 in patients with bone metastases of cancer. Oncol Lett. 2018;15(2):1545–1548.
   PubMed Web of Science ®Google Scholar
• Xin Y, Huang M, Guo WW, et al. Nano-based delivery of RNAi in cancer therapy. Mol Cancer. 2017;16(1):134–139.
   PubMed Web of Science ®Google Scholar
• Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 2004;432(7014):173–178.
   PubMed Web of Science ®Google Scholar
• Devi GR. siRNA-based approaches in cancer therapy. Cancer Gene Ther. 2006;13(9):819–829.
   PubMed Web of Science ®Google Scholar
• Wang J, Lu Z, Wientjes MG, et al. Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 2010;12(4):492–503.
   PubMed Web of Science ®Google Scholar
• Lee JM, Yoon TJ, Cho YS. Recent developments in nanoparticle-based siRNA delivery for cancer therapy. BioMed Res Int. 2013;2013:1–10.
   Web of Science ®Google Scholar
• Lunavat TR, Jang SC, Nilsson L, et al. RNAi delivery by exosome-mimetic nanovesicles – implications for targeting c-Myc in cancer. Biomaterials. 2016;102:231–238.
   PubMed Web of Science ®Google Scholar
• Setten RL, Rossi JJ, Han S. The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov. 2019;18(6):421–446.
   PubMed Web of Science ®Google Scholar
• Öztürk AA, Martin-Banderas L, Cayero-Otero MD, et al. New approach to hypertension treatment: carvediol-loaded PLGA nanoparticles, preparation, in vitro characterization and gastrointestinal stability. Trop J Pharm Res. 2018;37(9):1730–1741.
   Google Scholar
• Khan N, Ameeduzzafar Khanna K, Bhatnagar A, et al. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: statistical design, characterization and in-vivo studies. Int J Biol Macromol. 2018;116:648–663.
   PubMed Web of Science ®Google Scholar
• Şenel B, Büyükköroğlu G, Yazan Y. Solid lipid and chitosan particulate systems for delivery of siRNA. Die Pharm. 2015;70(11):698–705.
   PubMed Web of Science ®Google Scholar
• Öztürk AA, Güven UM, Yenilmez E, et al. Effects of different derivatives of eudragit polymer on entrapment efficiency, in vitro dissolution, release kinetics and cell viability results on extended release flurbiprofen loaded nanomedicines. Lat Am J Pharm. 2018;37(10):1981–1992.
   Web of Science ®Google Scholar
• Yılmaz-Usta D, Demirtaş Ö, Ökçelik C, et al. Evaluation of in vitro dissolution characteristics of flurbiprofen, a BCS class IIa drug. FABAD J Pharm Sci. 2018;43(2):117–124.
   Google Scholar
• Matias R, Ribeiro PRS, Sarraguca MC, et al. A UV spectrophotometric method for the determination of folic acid in pharmaceutical tablets and dissolution tests. Anal Methods. 2014;6(9):3065–3071.
   Web of Science ®Google Scholar
• Öztürk AA, Martin-Banderas L, Cayero-Otero MD, et al. Dexketoprofen trometamol-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles: preparation, in vitro characterization and cytotoxicity. Trop J Pharm Res. 2019;18(1):1–11.
   Web of Science ®Google Scholar
• Dizaj SM, Jafari S, Khosroushahi AY. A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res Lett. 2014;9(1):252.
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong K, et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev. 1999;51(4):691–743.
   PubMed Web of Science ®Google Scholar
• Ragelle H, Vandermeulen G, Préat V. Chitosan-based siRNA delivery systems. J Control Release. 2013;172(1):207–218.
   PubMed Web of Science ®Google Scholar
• Haussecker D. The business of RNAi therapeutics. Hum Gene Ther. 2008;19(5):451–462.
   PubMed Web of Science ®Google Scholar
• Kang F, Singh J. Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits. AAPS Pharm Sci Tech. 2005;6:487–494.
   PubMed Web of Science ®Google Scholar
• Rezvantalab S, Drude NI, Moraveji MK, et al. PLGA-based nanoparticles in cancer treatment. Front Pharmacol. 2018;9:1–19.
   PubMed Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems—a review (part 1). Trop J Pharm Res. 2013;12(2):255–264.
   Web of Science ®Google Scholar
• de Lima IA, Khalil NM, Tominaga TT, et al. Mucoadhesive chitosan- coated PLGA nanoparticles for oral delivery of ferulic acid. Artif Cells Nanomed Biotechnol. 2018;46(Suppl. 2):993–1002.
   PubMedGoogle Scholar
• Perez-Herrero E, Fernandez-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79.
   PubMed Web of Science ®Google Scholar
• Ripamonti CI, Bandieri E, Roila F. ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(6):69–77.
   Google Scholar
• Arslan D, Tatlı AM, Üyetürk Ü. Kansere bağlı ağrı ve tedavisi. Turk J Bioch. 2013;2(3):256–260.
   Google Scholar
• Heinz H, Pramanik C, Heinz O, et al. Nanoparticle decoration with surfactants: molecular interactions, assembly, and applications. Surf Sci Rep. 2017;72(1):1–58.
   Web of Science ®Google Scholar
• Ilkan MGY, Özdemir N. Investigation of the parameters affecting the release of flurbiprofen from chitosan microspheres. Braz J Pharm Sci. 2017;53(4):1–12.
   Web of Science ®Google Scholar
• Dora CP, Singh SK, Kumar S, et al. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Pol Pharm. 2010;67(3):283–290.
   PubMed Web of Science ®Google Scholar
• Zirak MB, Pezeshi A. Effect of surfactant concentration on the particle size, stability and potential zeta of beta carotene nano lipid carrier. Intl J Curr Microbiol App Sci. 2015;4(9):924–932.
   Google Scholar
• Mainardes R, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290(1–2):137–144.
   PubMedGoogle Scholar
• Koppolu B, Rahimi M, Nattama S, et al. Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomedicine. 2010;6(2):355–361.
   PubMed Web of Science ®Google Scholar
• Song H, Su C, Cui W, et al. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery. BioMed Res Int. 2013;2013:1–6.
   Google Scholar
• Menon JU, Kona S, Wadajkar AS, et al. Effects of surfactants on the properties of PLGA nanoparticles. J Biomed Mater Res A. 2012;100(8):1998–2005.
   PubMed Web of Science ®Google Scholar
• Büyükköroğlu G, Şenel B, Başaran E, et al. Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel loaded SLNs for cervical cancer. Eur J Pharm Biopharm. 2016;109:174–183.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Gupta R, Saraf SA. PLGA nanoparticles of anti tubercular drug: drug loading and release studies of a water in-soluble drug. Int J Pharm Tech Res. 2010;2:2116–2123.
   Google Scholar
• Song KC, Lee HS, Choung IY, et al. The effect of type of organic phase solvents on the particle size of poly(d,l-lactide-co-glycolide) nanoparticles. Colloids Surf A. 2006;276(1–3):162–167.
   Google Scholar
• Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002;62(21):6132–6140.
   PubMed Web of Science ®Google Scholar
• Shen S, Wu Y, Liu Y, et al. High drug-loading nanomedicines: progress, current status, and prospects. Int J Nanomedicine. 2017;12:4085–4109.
   PubMed Web of Science ®Google Scholar
• Senapati S, Mahanta AK, Kumar S, et al. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Targeted Ther. 2018;3(7):1–19.
   PubMedGoogle Scholar
• Martín-Banderas L, Alvarez-Fuentes J, Durán-Lobato M, et al. Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomedicine. 2012;7:5793–5806.
   PubMed Web of Science ®Google Scholar
• Ji J, Zuo P, Wang Y-L. Enhanced antiproliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticles. Nanoscale Res Lett. 2015;10(1):1–8.
   PubMedGoogle Scholar
• Fredenberg S, Wahlgren M, Reslow M, et al. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—a review. Int J Pharm. 2011;415(1–2):34–52.
   PubMed Web of Science ®Google Scholar
• Ansary RH, Awang MB, Rahman MM. Biodegradable poly(d,l-lactic-co-glycolic acid)-based micro/nanoparticles for sustained release of protein drugs-A review. Trop J Pharm Res. 2014;13(7):1179–1190.
   Web of Science ®Google Scholar
• Berkland C, Kim K, Pack DW. PLGA microsphere size controls drug release rate through several competing factors. Pharm Res. 2003;20(7):1055–1062.
   PubMed Web of Science ®Google Scholar
• Singh PK, Sah P, Meher JG, et al. Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis. RSC Adv. 2016;6(75):71705–71718.
   Web of Science ®Google Scholar
• Huang WZC. Tuning the size of poly(lactic-co-glycolic acid) (PLGA) nanoparticles fabricated by nanoprecipitation. Biotechnol J. 2018;13(1):1–19.
   Web of Science ®Google Scholar
• Sohail MF, Shah PA, Tariq I, et al. Development and in vitro evaluation of flurbiprofen microcapsules prepared by modified solvent evaporation technique. Trop J Pharm Res. 2014;13(7):1031–1038.
   Web of Science ®Google Scholar
• Paradkar A, Maheshwari M, Tyagi AM, et al. Preparation and characterization of flurbiprofen beads by melt solidification technique. AAPS Pharm Sci Tech. 2003;4(4):1–9.
   Google Scholar
• Nayak G, Trivedi MK, Branton A, et al. Consciousness energy healing treatment: impact on the physicochemical and thermal characteristics of folic acid. Int J Nutr. 2018;3(1):30–42.
   Google Scholar
• Varshosaz J, Hassanzadeh F, Aliabadi HS, et al. Synthesis and characterization of folate-targeted dextran/retinoic acid micelles for doxorubicin delivery in acute leukemia. BioMed Res Int. 2014;2014:1–14.
   Web of Science ®Google Scholar
• Singh G, Kaur T, Kaur R, et al. Recent biomedical applications and patents on biodegradable polymer-PLGA. Int J Pharmacol Pharm Sci. 2014;1(2):30–42.
   Google Scholar
• Queiroz MF, Melo KRT, Sabry DA, et al. Does the use of chitosan contribute to oxalate kidney stone formation? Mar Drugs. 2015;13(1):141–158.
   Web of Science ®Google Scholar
• Chuacharoen T, Sabliov CM. Zein nanoparticles as delivery systems for covalently linked and physically entrapped folic acid. J Nanopart Res. 2017;19(2):1–12.
   Web of Science ®Google Scholar
• Jin H, Pi J, Yang F, et al. Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep. 2016;6(30782):1–11.
   PubMedGoogle Scholar
• Zhao F, Zhao Y, Liu Y, et al. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011;7(10):1322–1337.
   PubMed Web of Science ®Google Scholar
• Lee KD, Choi SH, Kim DH, et al. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting. Arch Pharm Res. 2014;37(12):1546–1553.
   PubMed Web of Science ®Google Scholar
• Li HL, He YX, Gao QH, et al. Folate-polyethylene glycol conjugated carboxymethyl chitosan for tumor-targeted delivery of 5-fluorouracil. Mol Med Rep. 2014;9(3):786–792.
   PubMed Web of Science ®Google Scholar
• Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials. 2006;27(9):2060–2065.
   PubMed Web of Science ®Google Scholar
• Li K, Liu Y, Zhang S, et al. Folate receptor-targeted ultrasonic PFOB nanoparticles: synthesis, characterization and application in tumor-targeted imaging. Int J Mol Med. 2017;39(6):1505–1515.
   PubMed Web of Science ®Google Scholar
• Fernández M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem Sci. 2018;9(4):790–810.
   PubMed Web of Science ®Google Scholar
• Kim YK, Jiang HL, Choi YJ, et al. Polymeric nanoparticles of chitosan derivatives as DNA and siRNA carriers. Vol. 243. In: Jayakumar R, Prabaharan M, Muzzarelli R, editors. Chitosan for biomaterials. I. Advances in polymer science. Heidelberg: Springer; 2011. p. 1–22.
   Google Scholar
• Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine. 2018;4(13):3921–3935.
   Google Scholar
• Banerjee K, Pru C, Pru JK, et al. STAT3 Knockdown induces tumor formation by MDA-MB-231 cells. Clin Oncol Res. 2018;1(1):2–8.
   PubMedGoogle Scholar
• Huh MS, Lee EJ, Koo H, et al. Polysaccharide-based nanoparticles for gene delivery. In: Cheng Y, editor. Polymeric gene delivery systems. Switzerland: Springer; 2017. p. 65–84.
   Google Scholar
• Marquez AR, Madu CO, Lu Y. An overview of various carriers for siRNA delivery. Oncomedicine. 2018;3:48–58.
   Google Scholar
• Riley MK, Vermerris W. Recent advances in nanomaterials for gene delivery—a review. Nanomaterials (Basel). 2017;7(5):94–19.
   Google Scholar
• Raja MAG, Katas H, Jing Wen T. Stability, intracellular delivery, and release of siRNA from chitosan nanoparticles using different cross-linkers. PLOS One. 2015; 10(6):1–19.
   Web of Science ®Google Scholar
• Kim TK, Eberwine JH. Mammalian cell transfection: the present and the future. Anal Bioanal Chem. 2010;397(8):3173–3178.
   PubMed Web of Science ®Google Scholar
• Hofland HE, Masson C, Iginla S, et al. Folate-targeted gene transfer in vivo. Mol Ther. 2002;5(6):739–744.
   PubMed Web of Science ®Google Scholar
• Zheng B, Yang S, Wang M, et al. Non-covalent nanocomplexes of folic acid and reducible polyethylenimine for survivin siRNA delivery. Anticancer Res. 2015; 35(10):5433–5441.
   PubMed Web of Science ®Google Scholar
• Du YZ, Cai LL, Li J, et al. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. Int J Nanomedicine. 2011;6:1559–1568.
   PubMed Web of Science ®Google Scholar